Review of National Medicines Policy - Allergy and Anaphylaxis Australia submission - 8 Oct 2021
Allergy & Anaphylaxis Australia (A&AA) lodged a submission to the Review of National Medicines Policy.
Included were submisions on:
Terms of Reference 1: Evaluate the current NMP objectives and determine whether these should be modified or additional objectives included. This includes consideration of the proposed Principles to be included within the NMP.
Terms of Reference 2: Consider the definition of medicines and whether the NMP needs to be expanded to include health technologies.
Terms of Reference 3. Assess the NMP’s utility in the context of rapidly evolving treatment options, population changes, interconnected relationships, and system-wide capacities.
Terms of Reference 4: Consider the centricity of the consumer within the NMP and whether it captures the diversity of consumers’ needs and expectations.
Terms of Reference 5: Identify options to improve the NMP’s governance; communications, implementation (including enablers) and evaluation.
Terms of Reference 6: Review the NMP partners and provide options for building greater accountability including addressing conflicts of interest
Review of National Medicines Policy AAA Submission. 8 October 2021265.25 KB